BK vs INO · P/E 17, $94.14B cap vs $88.0M cap
The Bank of New York Mellon Corporation (BK) versus Inovio Pharmaceuticals Inc (INO) — a side-by-side from cached financials, not a winner call.
The Bank of New York Mellon Corporation (BK) is a banks - diversified company listed on US.
Inovio Pharmaceuticals Inc (INO) is a biotechnology company listed on US.
BK does not have a complete income-statement cache yet.
Latest reported INO revenue for 2026-06-30 was $0. Net income was -$6.0M. INO currently screens at market cap $88.0M.
BK currently screens at market cap $94.14B and trailing P/E 17.0. INO currently screens at market cap $88.0M.
Not investment advice. Open the BK and INO stock pages for the full models.
Not investment advice.